Recent Securities Litigations

Organogenesis Holdings Inc. Class A Common Stock (NASDAQ: ORGO)

23 Days left to seek lead plaintiff status.

Company Name:Organogenesis Holdings Inc. Class A Common Stock
Stock Symbol:NASDAQ: ORGO
Class Period Start:03/17/2021
Class Period End (inclusive):10/11/2021
Filing Deadline:02/08/2022

The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and prospects. Specifically, the Complaint alleges Defendants made false and/or misleading statements and/or failed to disclose that: (i) Organogenesis improperly billed the federal government for its Affinity and PuraPly XT products by, among other things, setting the price for those products multiple times higher than similar products; (ii) the Company improperly induced doctors to use its Affinity and PuraPly XT products through lucrative reimbursements; (iii) as a result of all the foregoing, the Company’s revenue and profits derived from its Affinity and PuraPly XT products were at least in substantial part unsustainable; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Organogenesis Holdings Inc. Class A Common Stock (NASDAQ: ORGO) Claim Form

Name(Required)
Address
Consent(Required)
This field is for validation purposes and should be left unchanged.